Ofatumumab/rituximabItching, rash, serum sickness and lack of efficacy: 6 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1933卷 / 1期

关键词：

D O I：

10.1007/s40278-022-28308-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：357 / 357

相关论文

共 50 条

[1] Ofatumumab/rituximabHypersensitivity reactions and serum sickness: 4 case reports
Reactions Weekly, 2017, 1652 (1) : 222 - 222
[2] CeftobiproleMyoclonus, erythematous skin rash and lack of efficacy: 6 case reports
Reactions Weekly, 2020, 1815 (1) : 92 - 92
[3] IbrutinibPneumonia, rash and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1905 (1) : 242 - 242
[4] CarbamazepineDrug rash and lack of efficacy: 2 case reports
Reactions Weekly, 2024, 2027 (1) : 111 - 111
[5] CrizotinibSkin rash and lack of efficacy : 2 case reports
Reactions Weekly, 2024, 2020 (1) : 159 - 159
[6] Ofatumumab/prednisone/rituximabVarious toxicities and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1956 (1) : 408 - 408
[7] Ofatumumab/rituximabSerum sickness, skin rash and flushing: case report
Reactions Weekly, 2020, 1794 (1) : 183 - 183
[8] Multiple drugsHypothyroidism, rash and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1958 (1) : 353 - 353
[9] AdalimumabPsoriasis like rash and lack of efficacy: 4 case reports
Reactions Weekly, 2023, 1953 (1) : 15 - 15
[10] TemozolomideGeneralised skin rash and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1889 (1) : 294 - 294

← 1 2 3 4 5 →